Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2022

Mar 17, 2022

30198_dirs_2022-03-17_a26cd6de-34b8-4296-a4b7-537fedd87b18.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2022-03-15

Reporting Person: SAYER KEVIN R (Director, Chairman, CEO & President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-15 Common Stock S 445 $405.84 Disposed 100438 Direct
2022-03-15 Common Stock S 405 $407.0 Disposed 100033 Direct
2022-03-15 Common Stock S 150 $407.6 Disposed 99883 Direct
2022-03-15 Common Stock S 400 $408.89 Disposed 99483 Direct
2022-03-15 Common Stock S 445 $410.0 Disposed 99038 Direct
2022-03-15 Common Stock S 405 $411.25 Disposed 98633 Direct
2022-03-15 Common Stock S 450 $412.27 Disposed 98183 Direct
2022-03-15 Common Stock S 50 $413.51 Disposed 98133 Direct
2022-03-15 Common Stock S 100 $414.99 Disposed 98033 Direct
2022-03-15 Common Stock S 150 $416.42 Disposed 97883 Direct

Footnotes

F1: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: This transaction was executed in multiple trades at prices ranging from $405.24 to $406.23. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: Included in this number are 33,698 unvested restricted stock units, 16,251 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 8,963 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

F4: This transaction was executed in multiple trades at prices ranging from $406.37 to $407.36. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F5: This transaction was executed in multiple trades at prices ranging from $407.48 to $408.055. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F6: This transaction was executed in multiple trades at prices ranging from $408.53 to $409.49. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F7: This transaction was executed in multiple trades at prices ranging from $409.67 to $410.56. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F8: This transaction was executed in multiple trades at prices ranging from $410.79 to $411.71. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F9: This transaction was executed in multiple trades at prices ranging from $411.91 to $412.41. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F10: This transaction was executed in multiple trades at prices ranging from $413.14 to $414.07. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F11: This transaction was executed in multiple trades at prices ranging from $416.13 to $417.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.